微芯生物(688321)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688321 微芯生物

已收盘 04-23 15:00:01

{"stockData":{"symbol":"688321","market":"SH","secType":"STK","nameCN":"微芯生物","latestPrice":16.64,"timestamp":1745391601000,"preClose":16.76,"halted":0,"volume":2685887,"delay":0,"changeRate":-0.0072,"floatShares":408000000,"shares":408000000,"eps":-0.1725,"marketStatus":"已收盘","change":-0.12,"latestTime":"04-23 15:00:01","open":16.9,"high":17.11,"low":16.56,"amount":45096300,"amplitude":0.0328,"askPrice":16.65,"askSize":1,"bidPrice":16.64,"bidSize":34,"shortable":0,"etf":0,"ttmEps":-0.1725,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745458200000},"marketStatusCode":5,"adr":0,"adjPreClose":16.76,"symbolType":"stock_kcb","openAndCloseTimeList":[[1745371800000,1745379000000],[1745384400000,1745391600000]],"highLimit":18.44,"lowLimit":15.08,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":407796477,"isCdr":false,"pbRate":4.47,"roa":"--","roe":"--","epsLYR":0.2176,"committee":0.541039,"marketValue":6786000000,"turnoverRate":0.0066,"status":1,"afterMarket":{"amount":0,"volume":0,"close":16.64,"buyVolume":0,"sellVolume":0,"time":1745393638029,"indexStatus":"已收盘 04-23 15:30:00","preClose":16.76},"floatMarketCap":6786000000},"requestUrl":"/m/hq/s/688321","defaultTab":"news","newsList":[{"id":"2529852226","title":"微芯生物04月23日遭主力抛售444万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529852226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529852226?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:23","pubTimestamp":1745392999,"startTime":"0","endTime":"0","summary":"04月23日, 微芯生物股价跌0.72%，报收16.64元，成交金额4509万元，换手率0.66%，振幅3.28%，量比0.85。微芯生物今日主力资金净流出444万元，上一交易日主力净流出22万元。该股近5个交易日上涨2.34%，主力资金累计净流出791万元；近20日主力资金累计净流出4038万元，其中净流出天数为15日。|04月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|健尔康|8.43%|#|新天地|7.95%|#|利安科技|7.56%|#|...|...|#3469|微芯生物|-0.07%|微芯生物所在的化学制药行业，今日主力净流出1.78亿元，行业排名28/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423165221a6c4ebc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423165221a6c4ebc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2529323763","title":"微芯生物04月22日主力净流出22万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2529323763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529323763?lang=zh_cn&edition=full","pubTime":"2025-04-22 15:22","pubTimestamp":1745306531,"startTime":"0","endTime":"0","summary":"04月22日, 微芯生物股价跌0.06%，报收16.76元，成交金额4233万元，换手率0.62%，振幅2.09%，量比0.71。微芯生物今日主力资金净流出22万元，上一交易日主力净流入23万元。该股近5个交易日上涨0.54%，主力资金累计净流出840万元；近20日主力资金累计净流出3212万元，其中净流出天数为14日。|04月22日主力加仓幅度排名||#|股票简称|主力净额占比|#|亚联机械|7.81%|#|华鹏飞|7.50%|#|泰禾股份|6.23%|#|...|...|#2281|微芯生物|-0.00%|微芯生物所在的化学制药行业，今日主力净流出3.03亿元，行业排名32/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422164851a46232ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422164851a46232ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2529809163","title":"美国关税或致药品短缺？行业警告：低利润仿制药面临停产危机","url":"https://stock-news.laohu8.com/highlight/detail?id=2529809163","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529809163?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:06","pubTimestamp":1745230017,"startTime":"0","endTime":"0","summary":"特朗普口中的“关税武器”，瞄准了全球仰赖的仿制药供应链。据央视新闻，美国或对进口药品征收关税。特朗普多次放话，药品可能被纳入征税范围。本周，美国商务部也宣布对药品进口是否构成“国家安全风险”启动调查。要知道，仿制药承担了美国约90%的药品供应，本身利润就极其微薄，加征关税一旦成真，部分药企或直接停产。目前美国大部分仿制药产自印度和东南亚，美国很难自给自足。事实上，美国药品供应紧张早已有苗头。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421180725a6c227a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421180725a6c227a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603669","603707","688247","600521","688799","600276","600774","688076","603538","600812","600664","600613","603229","603168","688166","600624","688578","688356","600267","603811","BK0239","603351","688758","600789","605116","688513","600079","603207","688321","688566","603676","688506"],"gpt_icon":0},{"id":"2529821511","title":"微芯生物04月21日主力净流入23万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529821511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529821511?lang=zh_cn&edition=full","pubTime":"2025-04-21 15:20","pubTimestamp":1745220014,"startTime":"0","endTime":"0","summary":"04月21日, 微芯生物股价涨4.03%，报收16.77元，成交金额6872万元，换手率1.02%，振幅4.96%，量比1.18。微芯生物今日主力资金净流入23万元，上一交易日主力净流出127万元。该股近5个交易日下跌0.77%，主力资金累计净流出274万元；近20日主力资金累计净流出2457万元，其中净流出天数为13日。|04月21日主力加仓幅度排名||#|股票简称|主力净额占比|#|青岛金王|9.86%|#|阳光乳业|9.01%|#|新金路|6.41%|#|...|...|#2449|微芯生物|0.00%|微芯生物所在的化学制药行业，今日主力净流入1.49亿元，行业排名34/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421160344a6c202bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421160344a6c202bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2528761022","title":"微芯生物04月17日遭主力抛售224万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528761022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528761022?lang=zh_cn&edition=full","pubTime":"2025-04-17 15:22","pubTimestamp":1744874540,"startTime":"0","endTime":"0","summary":"04月17日, 微芯生物股价跌0.62%，报收16.16元，成交金额5214万元，换手率0.78%，振幅2.64%，量比0.72。微芯生物今日主力资金净流出224万元，上一交易日主力净流出493万元。|04月17日主力加仓幅度排名||#|股票简称|主力净额占比|#|N宏工科技|22.61%|#|西陇科学|7.22%|#|红宝丽|7.12%|#|...|...|#3236|微芯生物|-0.03%|微芯生物所在的化学制药行业，今日主力净流入2.73亿元，行业排名12/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417163839a6bdac89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417163839a6bdac89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2518926157","title":"微芯生物：公司搭建了基于化学基因组学的集成式药物发现及早期评价平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2518926157","media":"互动易","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518926157?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:24","pubTimestamp":1741681442,"startTime":"0","endTime":"0","summary":"有投资者向微芯生物提问， 有消息报导，深圳微芯生物公司2024年有量产微流控芯片用于癌症早筛，指甲盖大小，成本20元左右，降低了筛查成本，请问此消息是否属实？公司回答表示，尊敬的投资者，您好！公司未布局微流控芯片用于癌症早筛。在芯片相关应用方面，公司搭建了“基于化学基因组学的集成式药物发现及早期评价平台”，该核心技术平台整合了分子医学、计算机辅助药物设计、药物化学及组合化学、高通量高内涵药物筛选、基因表达谱芯片（微阵列基因芯片）、生物信息学和化学信息学分析及软件支持等内容，可有效地降低新药的后期开发风险。感谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311163554a1d49232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311163554a1d49232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2518796859","title":"微芯生物：公司已开展DeepSeek本地化部署","url":"https://stock-news.laohu8.com/highlight/detail?id=2518796859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518796859?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:21","pubTimestamp":1741681314,"startTime":"0","endTime":"0","summary":"证券之星消息，微芯生物03月11日在投资者关系平台上答复投资者关心的问题。请问贵公司是否已经部署了DeepSeek？公司接入DeepSeek有哪些成本、收益方面的考量？如果公司计划在未来再进行部署，计划将DeepSeek应用于什么具体的业务呢？公司目前使用华为盘古大模型实现辅助药物分子设计。此外，目前公司已开展DeepSeek本地化部署。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100028055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321"],"gpt_icon":0},{"id":"2518579686","title":"微芯生物：公司未布局微流控芯片用于癌症早筛","url":"https://stock-news.laohu8.com/highlight/detail?id=2518579686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518579686?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:21","pubTimestamp":1741681300,"startTime":"0","endTime":"0","summary":"证券之星消息，微芯生物03月11日在投资者关系平台上答复投资者关心的问题。投资者提问：有消息报导，深圳微芯生物公司2024年有量产微流控芯片用于癌症早筛，指甲盖大小，成本20元左右，降低了筛查成本，请问此消息是否属实？公司未布局微流控芯片用于癌症早筛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100028043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159813","BK0239","688321"],"gpt_icon":0},{"id":"2518968237","title":"微芯生物：西格列他钠在脂肪肝治疗中展现优异初步疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=2518968237","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518968237?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:21","pubTimestamp":1741681277,"startTime":"0","endTime":"0","summary":"脂肪肝是2型糖尿病的常见合并症，西格列他钠（双洛平）在脂肪肝治疗中展现优异的初步疗效，II期临床试验结果已于2024年美国肝病年会口头报告。每日服用64mg西格列他钠（双洛平）18周显著降低肝脏脂肪含量、有效缓解肝纤维化、改善肝脏损伤，转氨酶明显下降。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100028031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2517967285","title":"微芯生物：西格列他钠（双洛平）可有效治疗糖尿病并改善高血脂症状","url":"https://stock-news.laohu8.com/highlight/detail?id=2517967285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517967285?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:21","pubTimestamp":1741162914,"startTime":"0","endTime":"0","summary":"西格列他钠（双洛平）具有降糖调脂、利肝安心的疗效。西格列他钠（双洛平）可有效治疗糖尿病并改善高血脂症状。西格列他钠（双洛平）在脂肪肝治疗中展现优异的初步疗效，II期临床试验结果已于2024年美国肝病年会口头报告。经非创“金标准”方式检测，每日服用64mg西格列他钠（双洛平）18周可显著降低肝脏脂肪含量、有效缓解肝纤维化、改善肝脏损伤，转氨酶明显下降。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030500027337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2517360062","title":"微芯生物获得发明专利授权：“一类酰肼类化合物、其制备方法及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2517360062","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517360062?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:47","pubTimestamp":1741114072,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示微芯生物新获得一项发明专利授权，专利名为“一类酰肼类化合物、其制备方法及其应用”，专利申请号为CN202211176559.0，授权日为2025年3月4日。本发明进一步还提供式I所示化合物的制备方法及其在治疗正痘病毒属相关病毒，如天花病毒、猴痘病毒、牛痘病毒、骆驼痘病毒麻、马痘病毒等相关病毒引起的相关疾病中的应用。今年以来微芯生物新获得专利授权1个，较去年同期减少了66.67%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030500002552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2516500758","title":"微芯生物：西格列他钠（双洛平）已纳入第十版《内学》教材，并获《中国糖尿病防治指南（2024版）》推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2516500758","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516500758?lang=zh_cn&edition=full","pubTime":"2025-03-03 17:00","pubTimestamp":1740992419,"startTime":"0","endTime":"0","summary":"西格列他钠（双洛平）已纳入第十版《内科学》教材，并获《中国糖尿病防治指南》推荐。自2021年上市以来，西格列他钠（双洛平）已被广泛用于糖尿病治疗，纳入指南和教科书是对西格列他钠疗效和安全性的极高认可。西格列他钠（双洛平）安全性良好，临床试验中未明显观察到其他糖尿病药物常见的胃肠道或尿路感染等不良反应。西格列他钠（双洛平）单用一般不增加低血糖风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030300022099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2516667504","title":"微芯生物：每日服用64mg西格列他钠（双洛平）18周显著降低肝脏脂肪含量、有效缓解肝纤维化（LSM下降近2kPa）、改善肝脏损伤，转氨酶明显下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2516667504","media":"互动易","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516667504?lang=zh_cn&edition=full","pubTime":"2025-03-03 16:00","pubTimestamp":1740988800,"startTime":"0","endTime":"0","summary":"有投资者向微芯生物提问， 董秘好，西格列他钠能治脂肪肝吗？公司回答表示，尊敬的投资者，您好！西格列他钠（双洛平）在脂肪肝（MASH/NASH）治疗中展现优异的初步疗效，II期临床试验结果已于2024年美国肝病年会口头报告。每日服用64mg西格列他钠（双洛平）18周显著降低肝脏脂肪含量、有效缓解肝纤维化（LSM下降近2kPa）、改善肝脏损伤，转氨酶明显下降。虽然目前该适应症仍未获批，但脂肪肝是2型糖尿病的常见合并症，公司积极关注糖尿病合并脂肪肝人群的用药需求。感谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303161529abe5b220&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303161529abe5b220&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688321","BK0239"],"gpt_icon":0},{"id":"2514386860","title":"【微芯生物(688321.SH)：2024年度净亏损1.15亿元】微芯生物(688321.SH)发布2024年度业绩快报，报告期内公司实现营业收入6.58亿元，同比增长25.63%;归属于母公司所有者的净亏损1.15亿元;归属于母公司所有者的扣除非经常性损益的净亏损2.05亿元;基本每股亏损0.2808元/股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386860","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386860?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:47","pubTimestamp":1740667647,"startTime":"0","endTime":"0","summary":"微芯生物(688321.SH)发布2024年度业绩快报，报告期内公司实现营业收入6.58亿元，同比增长25.63%;归属于母公司所有者的净亏损1.15亿元;归属于母公司所有者的扣除非经常性损益的净亏损2.05亿元;基本每股亏损0.2808元/股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27224748438680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688321"],"gpt_icon":0},{"id":"2514877125","title":"微芯生物2024年度业绩快报：归母净利润为-1.15亿元 同比减少228.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514877125","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514877125?lang=zh_cn&edition=full","pubTime":"2025-02-27 18:51","pubTimestamp":1740653500,"startTime":"0","endTime":"0","summary":"2月27日，微芯生物发布公告，2024年度业绩快报显示，公司营业总收入为6.58亿元，同比增长25.63%。主要增长原因是公司产品西达本胺和西格列他钠销量大幅提升。然而，归母净利润为-1.15亿元，同比减少228.97%；归母净利润扣除非经常性损益后为-2.05亿元，同比减亏5.62%。基本每股收益为-0.2808元，同比下降229.04%。整体来看，尽管营业收入实现增长，归母净利润的显著下降反映出公司面临的挑战。2024年前三季度，微芯生物实现收入4.81亿元，归母净利润-5108万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227185320963272df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227185320963272df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688321"],"gpt_icon":0},{"id":"2514187469","title":"微芯生物发布2024年度业绩快报，亏损1.146亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514187469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514187469?lang=zh_cn&edition=full","pubTime":"2025-02-27 18:31","pubTimestamp":1740652261,"startTime":"0","endTime":"0","summary":"证券之星消息，微芯生物近日即将发布2024年年报，根据2月27日发布的业绩快报，归属净利润亏损1.146亿元，同比减少228.97%。公司 2024 年度营业收入实现大幅增长，归属于母公司所有者的扣除非经常性损益的净利润实现同比减亏。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022700033866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688321"],"gpt_icon":0},{"id":"2514052460","title":"微芯生物02月25日主力净流出179万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2514052460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514052460?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:21","pubTimestamp":1740468092,"startTime":"0","endTime":"0","summary":"02月25日, 微芯生物股价跌1.30%，报收18.21元，成交金额6438万元，换手率0.86%，振幅1.63%，量比0.73。微芯生物今日主力资金净流出179万元，上一交易日主力净流入311万元。该股近5个交易日上涨2.48%，主力资金累计净流入1068万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出4162万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225162407a2531bb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225162407a2531bb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688321","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1745414743183,"stockEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.0811},{"period":"3month","weight":-0.017},{"period":"6month","weight":-0.2804},{"period":"1year","weight":-0.1892},{"period":"ytd","weight":-0.098}],"compareEarnings":[{"period":"1week","weight":0.0098},{"period":"1month","weight":-0.0193},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0059},{"period":"1year","weight":0.0838},{"period":"ytd","weight":-0.0155}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳微芯生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18601人(较上一季度减少4.63%)","perCapita":"21923股","listingDate":"2019-08-12","address":"广东省深圳市南山区西丽街道曙光社区智谷产业园B栋21F-24F","registeredCapital":"40779万元","survey":"　　深圳微芯生物科技股份有限公司的主营业务为药物技术开发、相关成果商业应用，主要产品均为自主研究发现与开发的新分子实体且作用机制新颖的原创新药。公司获得2020中国医药工业信息中心颁发的“中国医药新锐创新力量”奖；2020年10月，公司获 得“2020中国化学制药行业成长型优秀企业品牌”与“2020中国化学制药行业抗肿瘤和免疫调节剂类优秀产品品牌”两个奖项。","listedPrice":20.43},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微芯生物(688321)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微芯生物(688321)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微芯生物,688321,微芯生物股票,微芯生物股票老虎,微芯生物股票老虎国际,微芯生物行情,微芯生物股票行情,微芯生物股价,微芯生物股市,微芯生物股票价格,微芯生物股票交易,微芯生物股票购买,微芯生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微芯生物(688321)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微芯生物(688321)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}